nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Mitoxantrone—sarcoma	0.165	0.243	CbGbCtD
Theophylline—CYP1A1—Dacarbazine—sarcoma	0.0932	0.138	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—sarcoma	0.072	0.106	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—sarcoma	0.0709	0.105	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—sarcoma	0.0559	0.0824	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—sarcoma	0.0416	0.0614	CbGbCtD
Theophylline—CYP3A4—Thiotepa—sarcoma	0.0394	0.0581	CbGbCtD
Theophylline—CYP2E1—Etoposide—sarcoma	0.0352	0.052	CbGbCtD
Theophylline—CYP2C8—Etoposide—sarcoma	0.0263	0.0388	CbGbCtD
Theophylline—CYP1A2—Etoposide—sarcoma	0.0204	0.0301	CbGbCtD
Theophylline—ADA—pleura—sarcoma	0.0187	0.152	CbGeAlD
Theophylline—CYP3A4—Mitoxantrone—sarcoma	0.0169	0.025	CbGbCtD
Theophylline—CYP3A4—Vincristine—sarcoma	0.0116	0.0172	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—sarcoma	0.0114	0.0169	CbGbCtD
Theophylline—CYP3A4—Etoposide—sarcoma	0.0107	0.0158	CbGbCtD
Theophylline—PDE5A—pulmonary artery—sarcoma	0.00916	0.0745	CbGeAlD
Theophylline—CYP3A4—Doxorubicin—sarcoma	0.00728	0.0107	CbGbCtD
Theophylline—HDAC2—Teniposide—Etoposide—sarcoma	0.0036	1	CbGdCrCtD
Theophylline—Respiratory arrest—Thiotepa—sarcoma	0.00325	0.0283	CcSEcCtD
Theophylline—PDE5A—endothelium—sarcoma	0.00287	0.0233	CbGeAlD
Theophylline—PDE4A—mammary gland—sarcoma	0.00272	0.0221	CbGeAlD
Theophylline—Epigastric pain—Mitoxantrone—sarcoma	0.00255	0.0222	CcSEcCtD
Theophylline—PDE3B—hematopoietic system—sarcoma	0.00224	0.0182	CbGeAlD
Theophylline—Inappropriate antidiuretic hormone secretion—Vincristine—sarcoma	0.00218	0.019	CcSEcCtD
Theophylline—HDAC2—mammary gland—sarcoma	0.00217	0.0176	CbGeAlD
Theophylline—PDE3B—connective tissue—sarcoma	0.00216	0.0176	CbGeAlD
Theophylline—ADA—myometrium—sarcoma	0.00198	0.0161	CbGeAlD
Theophylline—ADA—hematopoietic system—sarcoma	0.0017	0.0138	CbGeAlD
Theophylline—Extravasation—Thiotepa—sarcoma	0.00164	0.0143	CcSEcCtD
Theophylline—ADORA2B—smooth muscle tissue—sarcoma	0.00164	0.0133	CbGeAlD
Theophylline—ADA—connective tissue—sarcoma	0.00164	0.0133	CbGeAlD
Theophylline—Extravasation—Dactinomycin—sarcoma	0.00163	0.0142	CcSEcCtD
Theophylline—ADORA2A—hematopoietic system—sarcoma	0.00155	0.0126	CbGeAlD
Theophylline—Hyperuricaemia—Thiotepa—sarcoma	0.00154	0.0134	CcSEcCtD
Theophylline—HDAC2—embryo—sarcoma	0.00148	0.012	CbGeAlD
Theophylline—Blood uric acid increased—Thiotepa—sarcoma	0.00146	0.0127	CcSEcCtD
Theophylline—Extravasation—Vincristine—sarcoma	0.00145	0.0127	CcSEcCtD
Theophylline—PDE3B—bone marrow—sarcoma	0.00144	0.0117	CbGeAlD
Theophylline—Sinus tachycardia—Epirubicin—sarcoma	0.00143	0.0124	CcSEcCtD
Theophylline—Extravasation—Mitoxantrone—sarcoma	0.00141	0.0123	CcSEcCtD
Theophylline—Dermatitis contact—Thiotepa—sarcoma	0.00141	0.0123	CcSEcCtD
Theophylline—PDE5A—hematopoietic system—sarcoma	0.00141	0.0115	CbGeAlD
Theophylline—CYP1B1—mammary gland—sarcoma	0.00139	0.0113	CbGeAlD
Theophylline—PDE3A—hematopoietic system—sarcoma	0.00137	0.0111	CbGeAlD
Theophylline—Hyperuricaemia—Vincristine—sarcoma	0.00137	0.0119	CcSEcCtD
Theophylline—PDE5A—connective tissue—sarcoma	0.00136	0.011	CbGeAlD
Theophylline—ADORA1—hematopoietic system—sarcoma	0.00134	0.0109	CbGeAlD
Theophylline—Hyperuricaemia—Mitoxantrone—sarcoma	0.00133	0.0116	CcSEcCtD
Theophylline—Sinus tachycardia—Doxorubicin—sarcoma	0.00132	0.0115	CcSEcCtD
Theophylline—HDAC2—hematopoietic system—sarcoma	0.00132	0.0107	CbGeAlD
Theophylline—Blood uric acid increased—Vincristine—sarcoma	0.00129	0.0112	CcSEcCtD
Theophylline—HDAC2—connective tissue—sarcoma	0.00127	0.0103	CbGeAlD
Theophylline—Blood uric acid increased—Mitoxantrone—sarcoma	0.00126	0.0109	CcSEcCtD
Theophylline—PDE5A—smooth muscle tissue—sarcoma	0.00124	0.0101	CbGeAlD
Theophylline—PDE4D—tendon—sarcoma	0.00124	0.0101	CbGeAlD
Theophylline—PDE3B—testis—sarcoma	0.00123	0.01	CbGeAlD
Theophylline—PDE3A—smooth muscle tissue—sarcoma	0.00121	0.00982	CbGeAlD
Theophylline—ADA—lymphoid tissue—sarcoma	0.0012	0.00974	CbGeAlD
Theophylline—Phlebitis—Dactinomycin—sarcoma	0.0012	0.0104	CcSEcCtD
Theophylline—Extravasation—Etoposide—sarcoma	0.00118	0.0102	CcSEcCtD
Theophylline—PDE3B—liver—sarcoma	0.00116	0.00945	CbGeAlD
Theophylline—HDAC2—smooth muscle tissue—sarcoma	0.00116	0.00945	CbGeAlD
Theophylline—Coma—Vincristine—sarcoma	0.00116	0.0101	CcSEcCtD
Theophylline—HDAC2—skin of body—sarcoma	0.00115	0.00933	CbGeAlD
Theophylline—ADA—tendon—sarcoma	0.00113	0.00915	CbGeAlD
Theophylline—Hyperuricaemia—Etoposide—sarcoma	0.00111	0.00964	CcSEcCtD
Theophylline—ADA—bone marrow—sarcoma	0.00109	0.00887	CbGeAlD
Theophylline—ADORA2A—lymphoid tissue—sarcoma	0.00109	0.00886	CbGeAlD
Theophylline—Venous thrombosis—Epirubicin—sarcoma	0.00107	0.00929	CcSEcCtD
Theophylline—CYP2C8—mammary gland—sarcoma	0.00106	0.00866	CbGeAlD
Theophylline—Polyuria—Vincristine—sarcoma	0.00105	0.00913	CcSEcCtD
Theophylline—Blood uric acid increased—Etoposide—sarcoma	0.00105	0.00911	CcSEcCtD
Theophylline—PDE3A—cardiac atrium—sarcoma	0.00104	0.00847	CbGeAlD
Theophylline—Phlebitis—Mitoxantrone—sarcoma	0.00104	0.00906	CcSEcCtD
Theophylline—PDE4D—testis—sarcoma	0.00103	0.00835	CbGeAlD
Theophylline—ADORA2B—testis—sarcoma	0.00102	0.00829	CbGeAlD
Theophylline—ADORA1—cardiac atrium—sarcoma	0.00101	0.00825	CbGeAlD
Theophylline—HDAC2—uterus—sarcoma	0.000997	0.00811	CbGeAlD
Theophylline—PDE4B—hematopoietic system—sarcoma	0.000988	0.00804	CbGeAlD
Theophylline—Urinary retention—Thiotepa—sarcoma	0.000987	0.00859	CcSEcCtD
Theophylline—Venous thrombosis—Doxorubicin—sarcoma	0.000987	0.00859	CcSEcCtD
Theophylline—PDE4D—liver—sarcoma	0.00097	0.00789	CbGeAlD
Theophylline—CYP2C9—mammary gland—sarcoma	0.000946	0.00769	CbGeAlD
Theophylline—PDE5A—tendon—sarcoma	0.000933	0.00758	CbGeAlD
Theophylline—ADA—testis—sarcoma	0.000932	0.00758	CbGeAlD
Theophylline—HDAC2—lymphoid tissue—sarcoma	0.000929	0.00756	CbGeAlD
Theophylline—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.000926	0.00806	CcSEcCtD
Theophylline—PDE4A—testis—sarcoma	0.000908	0.00739	CbGeAlD
Theophylline—PDE3A—tendon—sarcoma	0.000907	0.00738	CbGeAlD
Theophylline—PDE3B—lymph node—sarcoma	0.000891	0.00725	CbGeAlD
Theophylline—ADORA1—tendon—sarcoma	0.000884	0.00719	CbGeAlD
Theophylline—Urinary retention—Vincristine—sarcoma	0.000875	0.00762	CcSEcCtD
Theophylline—HDAC2—tendon—sarcoma	0.000873	0.0071	CbGeAlD
Theophylline—Phlebitis—Etoposide—sarcoma	0.000865	0.00753	CcSEcCtD
Theophylline—ADORA2A—testis—sarcoma	0.000848	0.0069	CbGeAlD
Theophylline—CYP1B1—hematopoietic system—sarcoma	0.000847	0.00689	CbGeAlD
Theophylline—HDAC2—bone marrow—sarcoma	0.000846	0.00688	CbGeAlD
Theophylline—SLC22A7—testis—sarcoma	0.00084	0.00683	CbGeAlD
Theophylline—Hypercalcaemia—Epirubicin—sarcoma	0.000828	0.00721	CcSEcCtD
Theophylline—Haematemesis—Epirubicin—sarcoma	0.000828	0.00721	CcSEcCtD
Theophylline—Abdominal pain upper—Mitoxantrone—sarcoma	0.000818	0.00713	CcSEcCtD
Theophylline—Hypokalaemia—Mitoxantrone—sarcoma	0.000815	0.0071	CcSEcCtD
Theophylline—CYP1B1—connective tissue—sarcoma	0.000815	0.00663	CbGeAlD
Theophylline—Hyperglycaemia—Thiotepa—sarcoma	0.000809	0.00705	CcSEcCtD
Theophylline—ADORA2A—liver—sarcoma	0.000802	0.00652	CbGeAlD
Theophylline—SLC22A7—liver—sarcoma	0.000794	0.00646	CbGeAlD
Theophylline—Ventricular arrhythmia—Epirubicin—sarcoma	0.000778	0.00677	CcSEcCtD
Theophylline—PDE5A—testis—sarcoma	0.000772	0.00628	CbGeAlD
Theophylline—Albuminuria—Epirubicin—sarcoma	0.000771	0.00671	CcSEcCtD
Theophylline—Anaphylactoid reaction—Etoposide—sarcoma	0.00077	0.00671	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—sarcoma	0.000766	0.00668	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—sarcoma	0.000766	0.00668	CcSEcCtD
Theophylline—Haematuria—Thiotepa—sarcoma	0.000762	0.00664	CcSEcCtD
Theophylline—PDE3A—testis—sarcoma	0.000751	0.00611	CbGeAlD
Theophylline—PDE4B—cardiac atrium—sarcoma	0.00075	0.0061	CbGeAlD
Theophylline—CYP1B1—smooth muscle tissue—sarcoma	0.000746	0.00607	CbGeAlD
Theophylline—PDE4D—lymph node—sarcoma	0.000744	0.00605	CbGeAlD
Theophylline—CYP1B1—skin of body—sarcoma	0.000736	0.00599	CbGeAlD
Theophylline—ADORA1—testis—sarcoma	0.000732	0.00595	CbGeAlD
Theophylline—HDAC2—testis—sarcoma	0.000723	0.00588	CbGeAlD
Theophylline—Ventricular arrhythmia—Doxorubicin—sarcoma	0.000719	0.00627	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—sarcoma	0.000713	0.00621	CcSEcCtD
Theophylline—PDE3A—liver—sarcoma	0.00071	0.00578	CbGeAlD
Theophylline—Hyperglycaemia—Mitoxantrone—sarcoma	0.000699	0.00608	CcSEcCtD
Theophylline—PDE4B—lymphoid tissue—sarcoma	0.000696	0.00566	CbGeAlD
Theophylline—HDAC2—liver—sarcoma	0.000684	0.00556	CbGeAlD
Theophylline—ADA—lymph node—sarcoma	0.000675	0.00549	CbGeAlD
Theophylline—Flushing—Dactinomycin—sarcoma	0.000661	0.00576	CcSEcCtD
Theophylline—Extravasation—Epirubicin—sarcoma	0.00066	0.00575	CcSEcCtD
Theophylline—Haematuria—Mitoxantrone—sarcoma	0.000658	0.00573	CcSEcCtD
Theophylline—PDE4A—lymph node—sarcoma	0.000658	0.00535	CbGeAlD
Theophylline—PDE4B—tendon—sarcoma	0.000654	0.00532	CbGeAlD
Theophylline—CYP2C8—hematopoietic system—sarcoma	0.000649	0.00527	CbGeAlD
Theophylline—Arrhythmia—Thiotepa—sarcoma	0.000641	0.00558	CcSEcCtD
Theophylline—CYP1B1—uterus—sarcoma	0.00064	0.0052	CbGeAlD
Theophylline—Ventricular extrasystoles—Epirubicin—sarcoma	0.000637	0.00555	CcSEcCtD
Theophylline—Alopecia—Thiotepa—sarcoma	0.000634	0.00552	CcSEcCtD
Theophylline—PDE4B—bone marrow—sarcoma	0.000633	0.00515	CbGeAlD
Theophylline—Alopecia—Dactinomycin—sarcoma	0.000629	0.00548	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—sarcoma	0.00062	0.0054	CcSEcCtD
Theophylline—Tension—Thiotepa—sarcoma	0.000613	0.00534	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—sarcoma	0.00061	0.00532	CcSEcCtD
Theophylline—CYP1A2—hematopoietic system—sarcoma	0.000607	0.00494	CbGeAlD
Theophylline—Nervousness—Thiotepa—sarcoma	0.000607	0.00529	CcSEcCtD
Theophylline—CYP1A1—hematopoietic system—sarcoma	0.000599	0.00487	CbGeAlD
Theophylline—CYP1B1—lymphoid tissue—sarcoma	0.000596	0.00485	CbGeAlD
Theophylline—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00059	0.00513	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—sarcoma	0.000586	0.0051	CcSEcCtD
Theophylline—CYP2C9—hematopoietic system—sarcoma	0.000576	0.00469	CbGeAlD
Theophylline—CYP2E1—seminal vesicle—sarcoma	0.000574	0.00467	CbGeAlD
Theophylline—Agitation—Thiotepa—sarcoma	0.000574	0.005	CcSEcCtD
Theophylline—Hyperuricaemia—Doxorubicin—sarcoma	0.000574	0.005	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—sarcoma	0.000569	0.00495	CcSEcCtD
Theophylline—Alopecia—Vincristine—sarcoma	0.000562	0.0049	CcSEcCtD
Theophylline—CYP1B1—tendon—sarcoma	0.00056	0.00456	CbGeAlD
Theophylline—PDE5A—lymph node—sarcoma	0.00056	0.00455	CbGeAlD
Theophylline—Arrhythmia—Mitoxantrone—sarcoma	0.000554	0.00482	CcSEcCtD
Theophylline—Alopecia—Mitoxantrone—sarcoma	0.000548	0.00477	CcSEcCtD
Theophylline—CYP2E1—hematopoietic system—sarcoma	0.000546	0.00444	CbGeAlD
Theophylline—PDE3A—lymph node—sarcoma	0.000544	0.00443	CbGeAlD
Theophylline—Blood uric acid increased—Doxorubicin—sarcoma	0.000542	0.00472	CcSEcCtD
Theophylline—PDE4B—testis—sarcoma	0.000541	0.0044	CbGeAlD
Theophylline—Convulsion—Thiotepa—sarcoma	0.000541	0.00472	CcSEcCtD
Theophylline—ADORA1—lymph node—sarcoma	0.000531	0.00432	CbGeAlD
Theophylline—Anxiety—Thiotepa—sarcoma	0.00053	0.00462	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—sarcoma	0.000526	0.00458	CcSEcCtD
Theophylline—Coma—Epirubicin—sarcoma	0.000526	0.00458	CcSEcCtD
Theophylline—HDAC2—lymph node—sarcoma	0.000524	0.00426	CbGeAlD
Theophylline—CYP1A1—skin of body—sarcoma	0.00052	0.00423	CbGeAlD
Theophylline—PDE4B—liver—sarcoma	0.000512	0.00416	CbGeAlD
Theophylline—Agitation—Vincristine—sarcoma	0.000509	0.00443	CcSEcCtD
Theophylline—Infection—Thiotepa—sarcoma	0.000507	0.00441	CcSEcCtD
Theophylline—Infection—Dactinomycin—sarcoma	0.000503	0.00438	CcSEcCtD
Theophylline—Nervous system disorder—Thiotepa—sarcoma	0.0005	0.00436	CcSEcCtD
Theophylline—Tachycardia—Thiotepa—sarcoma	0.000498	0.00433	CcSEcCtD
Theophylline—Coma—Doxorubicin—sarcoma	0.000487	0.00424	CcSEcCtD
Theophylline—Anorexia—Thiotepa—sarcoma	0.000486	0.00423	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—sarcoma	0.000485	0.00422	CcSEcCtD
Theophylline—Anorexia—Dactinomycin—sarcoma	0.000482	0.0042	CcSEcCtD
Theophylline—Convulsion—Vincristine—sarcoma	0.00048	0.00418	CcSEcCtD
Theophylline—Flushing—Etoposide—sarcoma	0.000478	0.00417	CcSEcCtD
Theophylline—Convulsion—Mitoxantrone—sarcoma	0.000468	0.00407	CcSEcCtD
Theophylline—CYP1B1—testis—sarcoma	0.000464	0.00377	CbGeAlD
Theophylline—Anxiety—Mitoxantrone—sarcoma	0.000458	0.00399	CcSEcCtD
Theophylline—Alopecia—Etoposide—sarcoma	0.000456	0.00397	CcSEcCtD
Theophylline—CYP1A1—cardiac atrium—sarcoma	0.000455	0.0037	CbGeAlD
Theophylline—Anaphylactic shock—Vincristine—sarcoma	0.000452	0.00394	CcSEcCtD
Theophylline—CYP1A1—uterus—sarcoma	0.000452	0.00368	CbGeAlD
Theophylline—Infection—Vincristine—sarcoma	0.000449	0.00391	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—sarcoma	0.000449	0.00391	CcSEcCtD
Theophylline—Nervous system disorder—Vincristine—sarcoma	0.000443	0.00386	CcSEcCtD
Theophylline—Decreased appetite—Thiotepa—sarcoma	0.000443	0.00386	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—sarcoma	0.000443	0.00386	CcSEcCtD
Theophylline—Anaphylactic shock—Mitoxantrone—sarcoma	0.00044	0.00384	CcSEcCtD
Theophylline—Decreased appetite—Dactinomycin—sarcoma	0.00044	0.00383	CcSEcCtD
Theophylline—CYP3A4—hematopoietic system—sarcoma	0.000439	0.00357	CbGeAlD
Theophylline—CYP1B1—liver—sarcoma	0.000439	0.00357	CbGeAlD
Theophylline—Infection—Mitoxantrone—sarcoma	0.000437	0.00381	CcSEcCtD
Theophylline—Shock—Mitoxantrone—sarcoma	0.000433	0.00377	CcSEcCtD
Theophylline—CYP2D6—hematopoietic system—sarcoma	0.000432	0.00352	CbGeAlD
Theophylline—Anaphylactoid reaction—Epirubicin—sarcoma	0.000432	0.00376	CcSEcCtD
Theophylline—Anorexia—Vincristine—sarcoma	0.000431	0.00375	CcSEcCtD
Theophylline—Tachycardia—Mitoxantrone—sarcoma	0.00043	0.00374	CcSEcCtD
Theophylline—Hypotension—Vincristine—sarcoma	0.000423	0.00368	CcSEcCtD
Theophylline—Anorexia—Mitoxantrone—sarcoma	0.00042	0.00366	CcSEcCtD
Theophylline—Gastrointestinal pain—Thiotepa—sarcoma	0.000417	0.00363	CcSEcCtD
Theophylline—Gastrointestinal pain—Dactinomycin—sarcoma	0.000414	0.0036	CcSEcCtD
Theophylline—Hypotension—Mitoxantrone—sarcoma	0.000411	0.00358	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00041	0.00357	CcSEcCtD
Theophylline—Insomnia—Vincristine—sarcoma	0.000409	0.00356	CcSEcCtD
Theophylline—Urticaria—Thiotepa—sarcoma	0.000405	0.00353	CcSEcCtD
Theophylline—Abdominal pain—Thiotepa—sarcoma	0.000403	0.00351	CcSEcCtD
Theophylline—Body temperature increased—Thiotepa—sarcoma	0.000403	0.00351	CcSEcCtD
Theophylline—Abdominal pain—Dactinomycin—sarcoma	0.0004	0.00348	CcSEcCtD
Theophylline—Body temperature increased—Dactinomycin—sarcoma	0.0004	0.00348	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000399	0.00348	CcSEcCtD
Theophylline—Decreased appetite—Vincristine—sarcoma	0.000393	0.00342	CcSEcCtD
Theophylline—PDE4B—lymph node—sarcoma	0.000392	0.00319	CbGeAlD
Theophylline—Convulsion—Etoposide—sarcoma	0.000389	0.00339	CcSEcCtD
Theophylline—CYP2E1—lymphoid tissue—sarcoma	0.000384	0.00313	CbGeAlD
Theophylline—Decreased appetite—Mitoxantrone—sarcoma	0.000383	0.00333	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—sarcoma	0.000382	0.00332	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—sarcoma	0.00038	0.00331	CcSEcCtD
Theophylline—Hypersensitivity—Thiotepa—sarcoma	0.000376	0.00327	CcSEcCtD
Theophylline—Hypersensitivity—Dactinomycin—sarcoma	0.000373	0.00325	CcSEcCtD
Theophylline—Gastrointestinal pain—Vincristine—sarcoma	0.00037	0.00322	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—sarcoma	0.000366	0.00319	CcSEcCtD
Theophylline—Infection—Etoposide—sarcoma	0.000364	0.00317	CcSEcCtD
Theophylline—CYP2E1—tendon—sarcoma	0.000361	0.00294	CbGeAlD
Theophylline—Pruritus—Thiotepa—sarcoma	0.000361	0.00314	CcSEcCtD
Theophylline—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00036	0.00314	CcSEcCtD
Theophylline—Tachycardia—Etoposide—sarcoma	0.000357	0.00311	CcSEcCtD
Theophylline—Body temperature increased—Vincristine—sarcoma	0.000357	0.00311	CcSEcCtD
Theophylline—Abdominal pain—Vincristine—sarcoma	0.000357	0.00311	CcSEcCtD
Theophylline—CYP2C8—testis—sarcoma	0.000355	0.00289	CbGeAlD
Theophylline—Abdominal pain upper—Doxorubicin—sarcoma	0.000353	0.00307	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—sarcoma	0.000352	0.00306	CcSEcCtD
Theophylline—Urticaria—Mitoxantrone—sarcoma	0.00035	0.00305	CcSEcCtD
Theophylline—Anorexia—Etoposide—sarcoma	0.000349	0.00304	CcSEcCtD
Theophylline—Diarrhoea—Thiotepa—sarcoma	0.000349	0.00304	CcSEcCtD
Theophylline—Abdominal pain—Mitoxantrone—sarcoma	0.000348	0.00303	CcSEcCtD
Theophylline—Body temperature increased—Mitoxantrone—sarcoma	0.000348	0.00303	CcSEcCtD
Theophylline—Diarrhoea—Dactinomycin—sarcoma	0.000346	0.00302	CcSEcCtD
Theophylline—Hypotension—Etoposide—sarcoma	0.000342	0.00298	CcSEcCtD
Theophylline—Dizziness—Thiotepa—sarcoma	0.000337	0.00294	CcSEcCtD
Theophylline—CYP1B1—lymph node—sarcoma	0.000336	0.00274	CbGeAlD
Theophylline—CYP2C8—liver—sarcoma	0.000336	0.00273	CbGeAlD
Theophylline—Hypersensitivity—Vincristine—sarcoma	0.000333	0.0029	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—sarcoma	0.000326	0.00284	CcSEcCtD
Theophylline—Hypersensitivity—Mitoxantrone—sarcoma	0.000324	0.00283	CcSEcCtD
Theophylline—Vomiting—Thiotepa—sarcoma	0.000324	0.00282	CcSEcCtD
Theophylline—Vomiting—Dactinomycin—sarcoma	0.000322	0.0028	CcSEcCtD
Theophylline—Rash—Thiotepa—sarcoma	0.000322	0.0028	CcSEcCtD
Theophylline—Dermatitis—Thiotepa—sarcoma	0.000321	0.0028	CcSEcCtD
Theophylline—Headache—Thiotepa—sarcoma	0.000319	0.00278	CcSEcCtD
Theophylline—Rash—Dactinomycin—sarcoma	0.000319	0.00278	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—sarcoma	0.000318	0.00277	CcSEcCtD
Theophylline—CYP1A2—liver—sarcoma	0.000314	0.00256	CbGeAlD
Theophylline—CYP1A1—liver—sarcoma	0.00031	0.00252	CbGeAlD
Theophylline—Diarrhoea—Vincristine—sarcoma	0.000309	0.00269	CcSEcCtD
Theophylline—Haematuria—Epirubicin—sarcoma	0.000307	0.00267	CcSEcCtD
Theophylline—Nausea—Thiotepa—sarcoma	0.000303	0.00264	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—sarcoma	0.000301	0.00262	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—sarcoma	0.000301	0.00262	CcSEcCtD
Theophylline—Nausea—Dactinomycin—sarcoma	0.000301	0.00262	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—sarcoma	0.0003	0.00261	CcSEcCtD
Theophylline—CYP2E1—testis—sarcoma	0.000299	0.00243	CbGeAlD
Theophylline—Dizziness—Vincristine—sarcoma	0.000299	0.0026	CcSEcCtD
Theophylline—CYP2C9—liver—sarcoma	0.000298	0.00243	CbGeAlD
Theophylline—Urticaria—Etoposide—sarcoma	0.000291	0.00253	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—sarcoma	0.00029	0.00252	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—sarcoma	0.00029	0.00252	CcSEcCtD
Theophylline—Vomiting—Vincristine—sarcoma	0.000288	0.0025	CcSEcCtD
Theophylline—Rash—Vincristine—sarcoma	0.000285	0.00248	CcSEcCtD
Theophylline—Dermatitis—Vincristine—sarcoma	0.000285	0.00248	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—sarcoma	0.000284	0.00247	CcSEcCtD
Theophylline—Headache—Vincristine—sarcoma	0.000283	0.00247	CcSEcCtD
Theophylline—CYP2E1—liver—sarcoma	0.000283	0.0023	CbGeAlD
Theophylline—Vomiting—Mitoxantrone—sarcoma	0.00028	0.00244	CcSEcCtD
Theophylline—Rash—Mitoxantrone—sarcoma	0.000278	0.00242	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—sarcoma	0.000277	0.00242	CcSEcCtD
Theophylline—Headache—Mitoxantrone—sarcoma	0.000276	0.0024	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—sarcoma	0.00027	0.00235	CcSEcCtD
Theophylline—Nausea—Vincristine—sarcoma	0.000269	0.00234	CcSEcCtD
Theophylline—Flushing—Epirubicin—sarcoma	0.000268	0.00234	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—sarcoma	0.000262	0.00228	CcSEcCtD
Theophylline—Pruritus—Etoposide—sarcoma	0.000259	0.00226	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—sarcoma	0.000258	0.00225	CcSEcCtD
Theophylline—Alopecia—Epirubicin—sarcoma	0.000255	0.00222	CcSEcCtD
Theophylline—Diarrhoea—Etoposide—sarcoma	0.000251	0.00218	CcSEcCtD
Theophylline—Flushing—Doxorubicin—sarcoma	0.000248	0.00216	CcSEcCtD
Theophylline—Tension—Epirubicin—sarcoma	0.000247	0.00215	CcSEcCtD
Theophylline—Nervousness—Epirubicin—sarcoma	0.000244	0.00213	CcSEcCtD
Theophylline—Dizziness—Etoposide—sarcoma	0.000242	0.00211	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—sarcoma	0.000239	0.00208	CcSEcCtD
Theophylline—CYP1A1—lymph node—sarcoma	0.000238	0.00193	CbGeAlD
Theophylline—CYP2D6—testis—sarcoma	0.000237	0.00193	CbGeAlD
Theophylline—Alopecia—Doxorubicin—sarcoma	0.000236	0.00206	CcSEcCtD
Theophylline—Vomiting—Etoposide—sarcoma	0.000233	0.00203	CcSEcCtD
Theophylline—Agitation—Epirubicin—sarcoma	0.000231	0.00201	CcSEcCtD
Theophylline—Rash—Etoposide—sarcoma	0.000231	0.00201	CcSEcCtD
Theophylline—Dermatitis—Etoposide—sarcoma	0.000231	0.00201	CcSEcCtD
Theophylline—Headache—Etoposide—sarcoma	0.000229	0.002	CcSEcCtD
Theophylline—Tension—Doxorubicin—sarcoma	0.000228	0.00199	CcSEcCtD
Theophylline—CYP3A4—liver—sarcoma	0.000228	0.00185	CbGeAlD
Theophylline—Nervousness—Doxorubicin—sarcoma	0.000226	0.00197	CcSEcCtD
Theophylline—CYP2D6—liver—sarcoma	0.000224	0.00182	CbGeAlD
Theophylline—Palpitations—Epirubicin—sarcoma	0.000222	0.00194	CcSEcCtD
Theophylline—Convulsion—Epirubicin—sarcoma	0.000218	0.0019	CcSEcCtD
Theophylline—Nausea—Etoposide—sarcoma	0.000218	0.0019	CcSEcCtD
Theophylline—Agitation—Doxorubicin—sarcoma	0.000214	0.00186	CcSEcCtD
Theophylline—Anxiety—Epirubicin—sarcoma	0.000213	0.00186	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—sarcoma	0.000206	0.00179	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—sarcoma	0.000205	0.00179	CcSEcCtD
Theophylline—Infection—Epirubicin—sarcoma	0.000204	0.00178	CcSEcCtD
Theophylline—Shock—Epirubicin—sarcoma	0.000202	0.00176	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—sarcoma	0.000202	0.00176	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—sarcoma	0.000201	0.00175	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—sarcoma	0.0002	0.00175	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—sarcoma	0.000197	0.00172	CcSEcCtD
Theophylline—Anorexia—Epirubicin—sarcoma	0.000196	0.0017	CcSEcCtD
Theophylline—Hypotension—Epirubicin—sarcoma	0.000192	0.00167	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—sarcoma	0.00019	0.00165	CcSEcCtD
Theophylline—Infection—Doxorubicin—sarcoma	0.000189	0.00164	CcSEcCtD
Theophylline—Shock—Doxorubicin—sarcoma	0.000187	0.00163	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—sarcoma	0.000186	0.00162	CcSEcCtD
Theophylline—Insomnia—Epirubicin—sarcoma	0.000186	0.00162	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—sarcoma	0.000185	0.00161	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—sarcoma	0.000181	0.00158	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—sarcoma	0.000178	0.00155	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—sarcoma	0.000178	0.00155	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—sarcoma	0.000172	0.0015	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—sarcoma	0.000168	0.00146	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—sarcoma	0.000165	0.00144	CcSEcCtD
Theophylline—Urticaria—Epirubicin—sarcoma	0.000163	0.00142	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—sarcoma	0.000162	0.00141	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—sarcoma	0.000162	0.00141	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—sarcoma	0.000155	0.00135	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—sarcoma	0.000151	0.00132	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—sarcoma	0.000151	0.00131	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—sarcoma	0.00015	0.00131	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—sarcoma	0.00015	0.00131	CcSEcCtD
Theophylline—Pruritus—Epirubicin—sarcoma	0.000145	0.00127	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—sarcoma	0.00014	0.00122	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—sarcoma	0.00014	0.00122	CcSEcCtD
Theophylline—Dizziness—Epirubicin—sarcoma	0.000136	0.00118	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—sarcoma	0.000134	0.00117	CcSEcCtD
Theophylline—Vomiting—Epirubicin—sarcoma	0.000131	0.00114	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—sarcoma	0.00013	0.00113	CcSEcCtD
Theophylline—Rash—Epirubicin—sarcoma	0.000129	0.00113	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—sarcoma	0.000129	0.00113	CcSEcCtD
Theophylline—Headache—Epirubicin—sarcoma	0.000129	0.00112	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—sarcoma	0.000126	0.00109	CcSEcCtD
Theophylline—Nausea—Epirubicin—sarcoma	0.000122	0.00106	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—sarcoma	0.000121	0.00105	CcSEcCtD
Theophylline—Rash—Doxorubicin—sarcoma	0.00012	0.00104	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—sarcoma	0.00012	0.00104	CcSEcCtD
Theophylline—Headache—Doxorubicin—sarcoma	0.000119	0.00104	CcSEcCtD
Theophylline—Nausea—Doxorubicin—sarcoma	0.000113	0.000983	CcSEcCtD
Theophylline—PDE4B—GPCR downstream signaling—IL2—sarcoma	3.38e-05	0.000417	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PDGFRB—sarcoma	3.38e-05	0.000417	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PDGFRA—sarcoma	3.36e-05	0.000415	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KIT—sarcoma	3.36e-05	0.000415	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—NRAS—sarcoma	3.36e-05	0.000415	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KDR—sarcoma	3.33e-05	0.000411	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PDGFRA—sarcoma	3.32e-05	0.00041	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL2—sarcoma	3.32e-05	0.00041	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—KRAS—sarcoma	3.25e-05	0.000401	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CREB1—sarcoma	3.24e-05	0.000401	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KDR—sarcoma	3.23e-05	0.000399	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL2—sarcoma	3.23e-05	0.000398	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CREB1—sarcoma	3.2e-05	0.000395	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KDR—sarcoma	3.18e-05	0.000392	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PLCG1—sarcoma	3.15e-05	0.000389	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL2—sarcoma	3.11e-05	0.000384	CbGpPWpGaD
Theophylline—HDAC2—Disease—KIT—sarcoma	3.09e-05	0.000382	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL2—sarcoma	3.07e-05	0.000379	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KIT—sarcoma	3.07e-05	0.000379	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—NRAS—sarcoma	3.07e-05	0.000379	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—EGFR—sarcoma	3.06e-05	0.000378	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KDR—sarcoma	3.02e-05	0.000373	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IGF1R—sarcoma	2.99e-05	0.000369	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KIT—sarcoma	2.97e-05	0.000367	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—NRAS—sarcoma	2.97e-05	0.000367	CbGpPWpGaD
Theophylline—HDAC2—Disease—CREB1—sarcoma	2.94e-05	0.000363	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KDR—sarcoma	2.94e-05	0.000363	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KIT—sarcoma	2.93e-05	0.000361	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—NRAS—sarcoma	2.93e-05	0.000361	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CREB1—sarcoma	2.92e-05	0.00036	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—KRAS—sarcoma	2.89e-05	0.000357	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—sarcoma	2.89e-05	0.000356	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—FOXO1—sarcoma	2.84e-05	0.000351	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PDGFRB—sarcoma	2.84e-05	0.00035	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CREB1—sarcoma	2.83e-05	0.00035	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KDR—sarcoma	2.83e-05	0.00035	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KDR—sarcoma	2.8e-05	0.000345	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—EGFR—sarcoma	2.79e-05	0.000345	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PDGFRA—sarcoma	2.79e-05	0.000345	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CREB1—sarcoma	2.79e-05	0.000344	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KIT—sarcoma	2.79e-05	0.000344	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—NRAS—sarcoma	2.79e-05	0.000344	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IGF1R—sarcoma	2.78e-05	0.000343	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—HRAS—sarcoma	2.76e-05	0.000341	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—EGFR—sarcoma	2.71e-05	0.000335	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KIT—sarcoma	2.71e-05	0.000334	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—NRAS—sarcoma	2.71e-05	0.000334	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—EGFR—sarcoma	2.67e-05	0.000329	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CREB1—sarcoma	2.65e-05	0.000327	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MDM2—sarcoma	2.65e-05	0.000327	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—FOXO1—sarcoma	2.64e-05	0.000326	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—IL2—sarcoma	2.64e-05	0.000326	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—KRAS—sarcoma	2.64e-05	0.000326	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PDGFRB—sarcoma	2.64e-05	0.000326	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KIT—sarcoma	2.61e-05	0.000322	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—NRAS—sarcoma	2.61e-05	0.000322	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PDGFRA—sarcoma	2.6e-05	0.000321	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CREB1—sarcoma	2.58e-05	0.000318	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KIT—sarcoma	2.58e-05	0.000318	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—NRAS—sarcoma	2.58e-05	0.000318	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—KRAS—sarcoma	2.56e-05	0.000316	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—EGFR—sarcoma	2.54e-05	0.000313	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—KRAS—sarcoma	2.52e-05	0.000311	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CREB1—sarcoma	2.48e-05	0.000306	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—EGFR—sarcoma	2.47e-05	0.000305	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—HRAS—sarcoma	2.46e-05	0.000304	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CREB1—sarcoma	2.45e-05	0.000303	CbGpPWpGaD
Theophylline—HDAC2—Disease—MDM2—sarcoma	2.44e-05	0.000301	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ENO2—sarcoma	2.42e-05	0.000299	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MDM2—sarcoma	2.42e-05	0.000298	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—HBA1—sarcoma	2.41e-05	0.000297	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL2—sarcoma	2.4e-05	0.000296	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—KRAS—sarcoma	2.4e-05	0.000296	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—EGFR—sarcoma	2.38e-05	0.000293	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL2—sarcoma	2.37e-05	0.000292	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KDR—sarcoma	2.35e-05	0.00029	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—EGFR—sarcoma	2.35e-05	0.00029	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MDM2—sarcoma	2.34e-05	0.000289	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—KRAS—sarcoma	2.33e-05	0.000288	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCND1—sarcoma	2.31e-05	0.000285	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MDM2—sarcoma	2.3e-05	0.000285	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—JUN—sarcoma	2.3e-05	0.000284	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ENO2—sarcoma	2.29e-05	0.000282	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CTNNB1—sarcoma	2.28e-05	0.000282	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—HBA1—sarcoma	2.27e-05	0.00028	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—KRAS—sarcoma	2.24e-05	0.000277	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—HRAS—sarcoma	2.24e-05	0.000277	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—KRAS—sarcoma	2.22e-05	0.000274	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MDM2—sarcoma	2.19e-05	0.000271	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KDR—sarcoma	2.19e-05	0.00027	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—HRAS—sarcoma	2.18e-05	0.000269	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KIT—sarcoma	2.17e-05	0.000267	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL2—sarcoma	2.16e-05	0.000266	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—HRAS—sarcoma	2.14e-05	0.000264	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MDM2—sarcoma	2.13e-05	0.000263	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCND1—sarcoma	2.1e-05	0.00026	CbGpPWpGaD
Theophylline—HDAC2—Disease—CTNNB1—sarcoma	2.1e-05	0.000259	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—JUN—sarcoma	2.1e-05	0.000259	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ENO2—sarcoma	2.09e-05	0.000259	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL2—sarcoma	2.09e-05	0.000258	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CTNNB1—sarcoma	2.08e-05	0.000257	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—HBA1—sarcoma	2.08e-05	0.000257	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—SRC—sarcoma	2.06e-05	0.000255	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CREB1—sarcoma	2.06e-05	0.000255	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL2—sarcoma	2.06e-05	0.000254	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PLCG1—sarcoma	2.06e-05	0.000254	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MDM2—sarcoma	2.05e-05	0.000254	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCND1—sarcoma	2.04e-05	0.000252	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—HRAS—sarcoma	2.04e-05	0.000252	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—JUN—sarcoma	2.04e-05	0.000251	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MDM2—sarcoma	2.03e-05	0.000251	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CTNNB1—sarcoma	2.02e-05	0.000249	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KIT—sarcoma	2.01e-05	0.000249	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—NRAS—sarcoma	2.01e-05	0.000249	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—VEGFA—sarcoma	2.01e-05	0.000248	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCND1—sarcoma	2.01e-05	0.000248	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—JUN—sarcoma	2e-05	0.000247	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CTNNB1—sarcoma	1.99e-05	0.000245	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—NRAS—sarcoma	1.99e-05	0.000245	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—HRAS—sarcoma	1.98e-05	0.000245	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL2—sarcoma	1.96e-05	0.000242	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PLCG1—sarcoma	1.94e-05	0.000239	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CREB1—sarcoma	1.92e-05	0.000237	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCND1—sarcoma	1.91e-05	0.000236	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—HRAS—sarcoma	1.91e-05	0.000236	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—JUN—sarcoma	1.91e-05	0.000235	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL2—sarcoma	1.91e-05	0.000235	CbGpPWpGaD
Theophylline—HDAC2—Disease—SRC—sarcoma	1.9e-05	0.000234	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CTNNB1—sarcoma	1.89e-05	0.000234	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—HRAS—sarcoma	1.89e-05	0.000233	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—SRC—sarcoma	1.88e-05	0.000233	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCND1—sarcoma	1.86e-05	0.000229	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—JUN—sarcoma	1.85e-05	0.000229	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MYC—sarcoma	1.85e-05	0.000228	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CTNNB1—sarcoma	1.84e-05	0.000227	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL2—sarcoma	1.84e-05	0.000227	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—EGFR—sarcoma	1.83e-05	0.000226	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—VEGFA—sarcoma	1.83e-05	0.000226	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—MYC—sarcoma	1.83e-05	0.000226	CbGpPWpGaD
Theophylline—HDAC2—Disease—NRAS—sarcoma	1.83e-05	0.000226	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—SRC—sarcoma	1.83e-05	0.000226	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL2—sarcoma	1.81e-05	0.000224	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—NRAS—sarcoma	1.81e-05	0.000224	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—EGFR—sarcoma	1.81e-05	0.000223	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SRC—sarcoma	1.8e-05	0.000222	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCND1—sarcoma	1.79e-05	0.000221	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—JUN—sarcoma	1.79e-05	0.00022	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—VEGFA—sarcoma	1.78e-05	0.00022	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PLCG1—sarcoma	1.78e-05	0.000219	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CTNNB1—sarcoma	1.77e-05	0.000219	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCND1—sarcoma	1.77e-05	0.000218	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—JUN—sarcoma	1.76e-05	0.000218	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—NRAS—sarcoma	1.76e-05	0.000217	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CTNNB1—sarcoma	1.75e-05	0.000216	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—VEGFA—sarcoma	1.75e-05	0.000216	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—KRAS—sarcoma	1.73e-05	0.000214	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—NRAS—sarcoma	1.73e-05	0.000213	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO2—sarcoma	1.72e-05	0.000212	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SRC—sarcoma	1.71e-05	0.000211	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HBA1—sarcoma	1.71e-05	0.000211	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KRAS—sarcoma	1.71e-05	0.000211	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MDM2—sarcoma	1.71e-05	0.000211	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO2—sarcoma	1.7e-05	0.00021	CbGpPWpGaD
Theophylline—HDAC2—Disease—MYC—sarcoma	1.7e-05	0.00021	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HBA1—sarcoma	1.69e-05	0.000209	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MYC—sarcoma	1.69e-05	0.000208	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—sarcoma	1.67e-05	0.000206	CbGpPWpGaD
Theophylline—HDAC2—Disease—EGFR—sarcoma	1.66e-05	0.000206	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SRC—sarcoma	1.66e-05	0.000205	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EGFR—sarcoma	1.65e-05	0.000204	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NRAS—sarcoma	1.65e-05	0.000203	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MYC—sarcoma	1.64e-05	0.000202	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—sarcoma	1.62e-05	0.0002	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MYC—sarcoma	1.61e-05	0.000199	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SRC—sarcoma	1.6e-05	0.000198	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EGFR—sarcoma	1.6e-05	0.000198	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NRAS—sarcoma	1.6e-05	0.000198	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MDM2—sarcoma	1.59e-05	0.000196	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SRC—sarcoma	1.58e-05	0.000195	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EGFR—sarcoma	1.57e-05	0.000194	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—sarcoma	1.57e-05	0.000194	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—sarcoma	1.56e-05	0.000193	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—sarcoma	1.56e-05	0.000193	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—sarcoma	1.54e-05	0.00019	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRAS—sarcoma	1.54e-05	0.00019	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—sarcoma	1.53e-05	0.000189	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—sarcoma	1.52e-05	0.000188	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—sarcoma	1.52e-05	0.000188	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—sarcoma	1.52e-05	0.000188	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—sarcoma	1.51e-05	0.000187	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—sarcoma	1.5e-05	0.000185	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—sarcoma	1.49e-05	0.000184	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—sarcoma	1.49e-05	0.000184	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—sarcoma	1.49e-05	0.000183	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—JUN—sarcoma	1.48e-05	0.000183	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—sarcoma	1.47e-05	0.000182	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—sarcoma	1.47e-05	0.000182	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PLCG1—sarcoma	1.46e-05	0.00018	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—sarcoma	1.46e-05	0.00018	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO2—sarcoma	1.46e-05	0.00018	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—sarcoma	1.45e-05	0.000179	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HBA1—sarcoma	1.45e-05	0.000179	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PLCG1—sarcoma	1.45e-05	0.000179	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—sarcoma	1.44e-05	0.000177	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—sarcoma	1.42e-05	0.000175	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—sarcoma	1.42e-05	0.000175	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—sarcoma	1.42e-05	0.000175	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—sarcoma	1.4e-05	0.000173	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—sarcoma	1.39e-05	0.000171	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—sarcoma	1.39e-05	0.000171	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—sarcoma	1.38e-05	0.000171	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—sarcoma	1.38e-05	0.00017	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—sarcoma	1.38e-05	0.00017	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—sarcoma	1.37e-05	0.000169	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—sarcoma	1.34e-05	0.000166	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—sarcoma	1.34e-05	0.000165	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SRC—sarcoma	1.33e-05	0.000164	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—sarcoma	1.33e-05	0.000164	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—sarcoma	1.33e-05	0.000164	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—sarcoma	1.32e-05	0.000163	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—sarcoma	1.31e-05	0.000162	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—sarcoma	1.3e-05	0.00016	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—sarcoma	1.29e-05	0.000159	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—sarcoma	1.28e-05	0.000158	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—sarcoma	1.26e-05	0.000156	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—sarcoma	1.26e-05	0.000155	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—sarcoma	1.24e-05	0.000153	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PLCG1—sarcoma	1.24e-05	0.000153	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—sarcoma	1.22e-05	0.000151	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—sarcoma	1.2e-05	0.000149	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—sarcoma	1.2e-05	0.000149	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—sarcoma	1.19e-05	0.000147	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—sarcoma	1.19e-05	0.000147	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—sarcoma	1.18e-05	0.000146	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—sarcoma	1.17e-05	0.000145	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—sarcoma	1.17e-05	0.000144	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—sarcoma	1.16e-05	0.000144	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—sarcoma	1.13e-05	0.000139	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—sarcoma	1.12e-05	0.000139	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HBA1—sarcoma	1.12e-05	0.000138	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—sarcoma	1.11e-05	0.000137	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—sarcoma	1.11e-05	0.000137	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—sarcoma	1.1e-05	0.000136	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—sarcoma	1.08e-05	0.000134	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—sarcoma	1.02e-05	0.000126	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—sarcoma	9.79e-06	0.000121	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLCG1—sarcoma	9.54e-06	0.000118	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—sarcoma	9.36e-06	0.000116	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—sarcoma	9.1e-06	0.000112	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—sarcoma	8.7e-06	0.000107	CbGpPWpGaD
